Anti-asthmatic effect of laurotetanine extracted from Litsea cubeba (Lour.) Pers. root on ovalbumin-induced allergic asthma rats, and elucidation of its mechanism of action

Abstract

Purpose: To investigate the anti-asthmatic effect of laurotetanine on allergic asthma rat model.
 Methods: Laurotetanine was extracted from the roots of Litsea cubeba (Lour.) Pers. Asthma was induced in rats by ovalbumin injection. Laurotetanine (20, 40, or 60 mg/kg) was administered orally to the rats for 21 days. Inflammatory cells and cytokines released by T-cell subsets Th1 and Th2 in the bronchoalveolar lavage fluid were determined. Serum immunoglobulin E (IgE) and histamine, in addition to expression of mucin 5AC (MUC-5AC), nuclear factor-kappa B (NF-κB), and an inhibitor of NF-κB (IκB) in lung tissues were also evaluated.
 Results: Laurotetanine treatment (20, 40, 60 mg/kg) significantly reduced inflammatory cells, including eosinophils, neutrophils, lymphocytes, and macrophages in treated rats compared with control animals (p < 0.01). Inflammatory cytokines, viz, interleukin (IL) -4, IL-6, IL-13 were also significantly (p < 0.01) decreased by laurotetanine treatment (20, 40, 60 mg/kg), whereas interferon gamma (IFN-γ) was increased (p < 0.01). Serum IgE and histamine were significantly reduced (p < 0.01) by laurotetanine (20, 40, 60 mg/kg). Furthermore, MUC5AC expression in lung tissues was significantly (p < 0.01) downregulated by laurotetanine (20, 40, and 60 mg/kg, but NF-κB and IκB were significantly (p < 0.01) upregulated by laurotetanine (20, 40, and 60 mg/kg).
 Conclusion: Laurotetanine exerts an anti-asthmatic effect in rats by inhibition of IgE, histamine, and inflammatory reactions via down-regulating MUC5AC and NF-κB signaling pathways. This finding justifies the need for further development of laurotetanine as a potential anti-asthmatic drug.

Screening of Potential Indonesia Herbal Compounds Based on Multi-Label Classification for 2019 Coronavirus Disease

“…Regarding similar compounds that emerged from the prediction results of the three SAE-DNN models, these compounds were predicted to have interactions with COVID-19 proteins. This is supported by several literature studies showing that Hyperoside, Aloin, Rhamnetin, Laurotetanine, and Isoquercetin compounds have anti-inflammatory properties [52][53][54][56][57][58], which can help fight the hyper inflammation process in COVID-19 patients. For Garcimangosone d, its efficacy on COVID-19 or the inflammatory process in the body is not yet known.…”

Norcantharidin alleviates cyclophosphamide induced immunosuppression and leukopenia in mice through NF κB pathway

“…Many studies have indicated that oxidative stress (imbalance between free radicals and antioxidants), inflammation, as well as reduced immunity are implicated in asthma. However, not much is known about the in-depth pathophysiology of asthma [4,5]. The current treatment regimens involve mostly inhalation drugs such as corticosteroids, anti-IgE drugs (monoclonal IgE antibodies), β2-adrenergic agonist, antileukotrienes/cholinergic (individual or combinational therapy), in addition to bronchial thermoplasty procedure.…”